Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on Sotagliflozin for Slowing Kidney Disease in Type 1 Diabetes Patients
DenmarkStudy on Filgrastim for Patients with Severe Bullous Drug Eruptions: Lyell and Stevens-Johnson Syndromes
FranceStudy on Leflunomide for Preventing Relapses in Patients with Polymyalgia Rheumatica During Steroid Reduction
The NetherlandsStudy on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Crohn's Disease
AustriaStudy on Isatuximab for Treating Pure Red Cell Aplasia in Patients with Major ABO Mismatch After Stem Cell Transplantation
FranceStudy on the Effectiveness and Safety of a Grass and Juniperus Oxycedrus Allergy Vaccine for Patients with Allergic Rhinitis or Rhinoconjunctivitis with or without Mild Asthma
SpainStudy on the Safety of MB-CART19.1 for Patients with Active Systemic Lupus Erythematosus, Systemic Sclerosis, or Dermatomyositis/Polymyositis
GermanyStudy on Rituximab for Achieving Remission in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
The NetherlandsStudy Comparing Doravirine and Dolutegravir-Based Treatments for People with HIV-1 Who Have Not Yet Started Therapy
FranceStudy Comparing Azathioprine and Methotrexate with Adalimumab for Patients with Crohn's Disease
FranceStudy on Atrasentan for Patients with IgA Nephropathy at Risk of Kidney Function Loss
FranceStudy on Anti-CD19 CAR T-Cell Therapy for Patients with Refractory Systemic Autoimmune Diseases Using Levetiracetam, Fludarabine, and a Drug Combination
ItalyThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
